Live tape
Top 8, mentions 7d9,131MRNA1,825 mentions▲ +0.09GOOGL1,641 mentions▲ +0.04META1,235 mentions▲ +0.04SNDK1,098 mentions▲ +0.10NVDA1,075 mentions▲ +0.07SPCX852 mentions▲ +0.08NKE729 mentions▲ +0.03MSFT676 mentions▲ +0.05

Equity · Consumer Cyclical

BFAM

Bright Horizons Family Solutions Inc. · NYSE

$73.11 +0.79% 1D Finazon · prior-day close · Aug 19, 2026
Price · Chart
Our own end-of-day closes 60 sessions
$90 $50 26 May 19 Aug

The line runs $65.04 on 26 May through $73.11 on 19 August, on a scale from $50 to $90. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BFAM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 60 sessions over that window: $65.04 on 26 May 2026 through $73.11 on 19 August 2026.

Market cap $3.6B
P/E (TTM) 19.6
52-week range $59 – $123.22
Avg volume 213.2K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 20, 2026

BFAM insider trades

SEC Form 4

BFAM has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 1 October 2025.

Date Insider Type Shares Value
01 Oct 2025 Burke Mary Lou COO North America Center Ops Sell 1,000 $109K
02 Sep 2025 Burke Mary Lou COO North America Center Ops Sell 1,000 $116K
05 Aug 2025 TOCIO MARY ANN Sell 3,000 $360K
01 Aug 2025 Burke Mary Lou COO North America Center Ops Sell 1,000 $129K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
05 Aug 2025 Marshall Rosamund Managing Director - Intl. Tax withheld 2,250 $265K

BFAM reported financials

SEC EDGAR XBRL

BFAM reported revenue of $2.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was $193.1M.

Figure Reported Period
Revenue $2.9B 31 Dec 2025 fiscal year
Net income $193.1M 31 Dec 2025 fiscal year
Diluted EPS $3.36 31 Dec 2025 fiscal year
Total assets $3.8B 30 Jun 2026 at period end
Total equity $943.5M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

BFAM earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.79 —
31 Mar 2026 Q1 2026 $0.62 —
31 Dec 2025 FY 2025 $3.36 —
30 Sep 2025 Q3 2025 $1.37 —
30 Jun 2025 Q2 2025 $0.95 —
31 Mar 2025 Q1 2025 $0.66 —
31 Dec 2024 FY 2024 $2.40 —
30 Sep 2024 Q3 2024 $0.94 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BFAM institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a BFAM position for the quarter ended 30 Jun 2026 — a combined $454.7M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
AQR Capital Management Held (±25%) −7.3% shares 3,084,745 $218.4M
Two Sigma Investments Held (±25%) −15.5% shares 1,144,465 $81.1M
Point72 Asset Management Added +59.4% shares 920,382 $65.2M
D. E. Shaw & Co. Held (±25%) −10.9% shares 454,593 $32.2M
Citadel Advisors Added +854.4% shares 291,904 $20.7M
Millennium Management Trimmed −83.0% shares 184,789 $13.1M
Man Group Held (±25%) +23.9% shares 159,165 $11.3M
Balyasny Asset Management New position 157,594 $11.2M
Marshall Wace Trimmed −93.5% shares 18,842 $1.3M
Bridgewater Associates Held (±25%) −5.1% shares 2,971 $211K

Source: SEC EDGAR 13F filings

BFAM fails-to-deliver

SEC CNS data

On 29 Jul 2026, 20 shares of BFAM failed to deliver (about $2K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
29 Jul 2026 20 $2K <0.001%
28 Jul 2026 21 $2K <0.001%
23 Jul 2026 9 $648 <0.001%
22 Jul 2026 5 $373 <0.001%
20 Jul 2026 62 $5K <0.001%
17 Jul 2026 1,510 $115K 0.003%
10 Jul 2026 112 $8K <0.001%
09 Jul 2026 112 $8K <0.001%
08 Jul 2026 209 $16K <0.001%

Source: SEC fails-to-deliver (CNS) data